Last10K.com

Zeta Acquisition Corp Ii (ARPO) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2012

SEC Filings

ARPO Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ARPO Annual Reports

ARPO Quarterly Reports

ARPO Corporate News

Aerpio Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1422142 Ticker: ARPO
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2012
Mar. 28, 2013
Entity Registrant Name ZETA ACQUISITION CORP II  
Entity Central Index Key 0001422142  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol zetaii  
Entity Common Stock, Shares Outstanding   5,000,000
Document Type 10-K  
Amendment Flag false  
Document Period End Date Dec. 31, 2012  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2012  
Entity Well-Known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Public Float $ 0  

View differences made from one year to another to evaluate Aerpio Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aerpio Pharmaceuticals, Inc..

Continue

Assess how Aerpio Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aerpio Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Aerpio Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Exhibit 32.2: Section 1350 Certification
Ticker: ARPO
CIK: 1422142
Form Type: 10-K Annual Report
Accession Number: 0001144204-13-018033
Submitted to the SEC: Thu Mar 28 2013 6:12:48 AM EST
Accepted by the SEC: Thu Mar 28 2013
Period: Monday, December 31, 2012
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/arpo/0001144204-13-018033.htm